Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New data on oseltamivir in H1N1 and H5N1 viruses discussed at ICAAC

Sep. 21, 2009

ONO-5334 shows potential for osteoporosis therapy in ovariectomized monkeys

Sep. 18, 2009

Botulinum toxin type A improves various Parkinson's disease symptoms

Sep. 18, 2009

TBR-652 in vitro activity in combination with antiretrovirals and human pharmacokinetics reported

Sep. 18, 2009

ACE-011 active against bone loss in postmenopausal women

Sep. 18, 2009

Sativex is well tolerated and improves spasticity due to multiple sclerosis in clinical trial

Sep. 18, 2009

Gilead presents studies of its pharmaco-enhancer GS-9350 in the treatment of HIV

Sep. 18, 2009

Phase I data show MGCD-290 to be well tolerated, with favorable pharmacokinetics

Sep. 17, 2009

Panobacumab safe in patients with hospital-acquired pneumonia

Sep. 17, 2009

In vivo anti-ulcerative activity exhibited by chitosan

Sep. 17, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...